| by admin | No comments

Scripps Clinics will open in India for the first time

Scripp’s Clinics in India has opened its doors to the public for the very first time.

The open-air clinics have been in operation for the past few years and are one of the first to be opened in the country.

“We are very happy to have opened Scripp Clinics here in India.

It has been a very difficult process to get approval from the Ministry of Health, but we are confident of this.

We have done everything to meet the government’s requirements,” said Dr Sanjay Sharma, the CEO of Scripp and a professor at the Centre for Human Resources Development (CHRD) in Mumbai.

“We are committed to the Indian market and want to take our brand of medicine to the next level,” he added.

The new Scripp clinic will be located at Juhu, a few kilometres from the city.

The opening of the new clinic marks the latest milestone in the journey of Sciplastis to India.

The company is currently in the process of registering a pharmaceutical license in India with the Medicines and Healthcare Products Regulatory Authority of India (MHRAI).

Earlier this year, Scripp also opened an office in the US, where it was granted a pharmaceutical licence.

The newly opened clinic will serve both the medical and recreational use of its patients.

“I am very excited to welcome Scripp Clinic patients here.

We hope that our patients will be able to benefit from our products, including new medicines and new services,” said Sharma.

The Scripp is India’s first new medical clinic in the last 15 years.

“It is also very exciting that we are opening up a new location in the Indian state of Gujarat.

We look forward to helping the patients and the community, and I am sure that our services will be of immense benefit,” said the CEO.

The clinic will also have a retail outlet.

The first patient is expected to arrive in the next few weeks. 

Dr Sanjay Sarma, who founded the company in 1998, said the company was started by people who wanted to bring the highest level of medical care to their patients. 

“We have been working for over 10 years on a global scale and in recent years we have developed a global network of more than 400 clinical facilities, which has helped us to expand our reach.

Our primary focus is on the treatment of the most serious diseases in our patients, which we are able to do through the services we offer,” he said.